JILL MCLAUGHLIN: Open Payments
NPI 1386096337 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 14 payments from 8 companies in 2025. Trend: 2023 $418 · 2024 $312 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Chiesi USA, Inc. | 2 | $42 |
| ABIOMED | 1 | $34 |
| Novo Nordisk Inc | 1 | $24 |
| Philips North America LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: REPATHA, Kerendia, JUXTAPID, Wegovy, MCOT, JARDIANCE, LEQVIO.
Industry payments across FL — which companies pay providers there.
